Search results

Collaborations 13

View all

• Scientific Instrumentation @ Wyss Collaboratories Program
  The Wyss Scientific Instrumentation @ Wyss Collaboratories Program is a unique collaboration between industry manufacturers and our community of scientists and engineers to drive progress and impact, spur entrepreneurship, and incubate innovation.
• Brain Targeted Therapeutic Collaboration
  Combine our shuttles with your drugs to create new brain targeted therapeutics for patients.
• Brain Shuttle Research Sponsorship & Licensing
  Enabling brain-targeted drug development through non-exclusive licensing and pre-competitive research sponsorship.
• Bridging the Funding Gap for Brain Therapeutics
  A unique opportunity to help develop a new generation of brain targeted drugs
• Brigham-Wyss DxA
  The Wyss DxA's clinical partners from Brigham and Women’s Hospital identify the most pressing unmet diagnostic needs, provide access to high-quality patient samples for our Biomarker Discovery Laboratory (BDL) and Brigham-Wyss DxA collaborators, and provide invaluable feedback and guidance on the engineering and validation of cost-effective, sensitive, and specific diagnostic tests.
• Biomarker Discovery Laboratory (BDL)
  Bridging the diagnostic gap from biomarker discovery to market-ready test kits and instruments through cutting-edge technology development and clinical collaboration.

News 7

View all

• Community
  
  A Year in Review: 2023
  December 28, 2023
• Translation News
  
  Harvard’s Wyss Institute and Collaborative Fund cofound research lab to fund technology to combat climate change
  May 23, 2023
• Press Release
  
  Wyss Institute’s Lab-on-a-Molecule Drug Discovery Project Receives Funding from Northpond Labs
  April 4, 2023

Multimedia 5

• 

  Video/Animation
  Reimagine the World – Volume 3 – Northpond Edition
  The Wyss Institute’s alliance with Northpond Labs supports early-stage, transformative research with strong translation potential. Hear Northpond Ventures co-founders Michael Rubin and Sharon Kedar explain why they decided to partner with the Wyss, as well as the leaders of various Wyss projects and startups about how support from Northpond has helped accelerate their technologies to...

• 

  Audio/Podcast
  Making Sugar Healthier – DDN Dialogues
  With some out-of-the-box engineering, researchers have developed a nature-inspired strategy to turn sugar in packaged foods into gut-healthy fiber. This podcast features Director of Business Development, Sam Inverso, Ph.D., and Senior Engineer Adama Sesay, Ph.D., along with Judith Moca and John Topinka from Kraft-Heinz. This episode was created and is owned by Drug Discovery News,...

• 

  Video/Animation
  Reimagine the World – Volume 2 – Diagnostics Accelerator
  Two clinicians collaborating with the Wyss Diagnostics Accelerator (DxA), Lise Johnson and Craig Hersh, as well as two members of the Wyss DxA Industrial Partnership Program, Nell Meosky Luo and Andy Levin, share how they would Reimagine the World and the personal stories that fuel their passion for the work they are doing. Credit: Wyss...

• 

  Video/Animation
  Wyss Diagnostics Accelerator – The Industrial Participant Program
  The Industrial Participant Program (IPP) is a collaboration hub between healthcare testing companies and the scientific and clinical community within the Wyss ecosystem, driven by the Wyss Diagnostics Accelerator (DxA). Members of the IPP share the common goal of fast-tracking diagnostic technologies to meet unmet, critical needs. Credit: Wyss Institute at Harvard University

• 

  Video/Animation
  Reimagining Health Equity: Wyss Diagnostics Accelerator
  With the Wyss Diagnostics Accelerator (DxA), we’re reimagining health equity by accelerating the development and deployment of needed diagnostics in all settings, particularly in low-resource settings, by fostering deep collaborations driven by unmet needs. Credit: Wyss Institute at Harvard University